Tag: Vital-IT group

  • All facilities

  • Focus on Clinical Bioinformatics: Bridging the gap between data science and medicine

    “Stick out your tongue and say... ‘omics’”.In addition to patients’ vital signs or eating habits, molecular profiling data is increasingly becoming part of the medical practitioners’ toolbox. But these ‘omics’ data pose novel challenges, for...

  • From infrastructure planning to implementation, BioMedIT progresses

    Update on the Swiss Personalized Health Network (SPHN) Designed to promote the development of personalized health in Switzerland, the SPHN initiative will lay the foundations to foster research projects in this area, including mechanisms...

  • Joining forces against hypoglycaemia and diabetes

    Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society - among which SIB's Vital-IT Group and the University of Lausanne - have joined forces to fight diabetes.

  • Novel molecular insights into diabetic beta cells

    Type 2 diabetes, which affects >0.5 billion people worldwide, results from the inability of pancreatic beta cells to provide the body with enough insulin to maintain healthy levels of blood glucose. As part of the IMIDIA initiative, an...

  • Oncobench: one day gained to fight cancer

    When it comes to fighting cancer, obtaining a diagnosis a day earlier, as well as saving one full day per week of clinical lab professionals’ precious time, can have important benefits for patients, hospitals and health insurance alike. This and...

  • sciCORE, VITAL-IT & Bioinformatics Core Facility (BCF): ARE YOU A USER?

    Fill the survey & win an Amazon voucher - SIB has commissioned an independent evaluation of its value for the life science community, and its economic impact. To this end, a survey was designed to quantify the impact of SIB's Core Facilities by...

  • SIB accelerates the fight against diabetes with several pan- European projects

    Recent advances in the fight against type 2 diabetes (T2D) result from a pan-European collaborative project, called IMIDIA, in which the SIB Swiss Institute of Bioinformatics is closely involved since 2010.

  • SIB Group Leader Prof. Xenarios is among the 100 distinguished personalities in Western Switzerland

    Entrepreneurs, Scientists, Journalists, Artists... Each year, the Forum des 100 lists and brings together 100 personalities who contribute to the dynamism and spirit of innovation of Western Switzerland.Prof. Ioannis Xenarios is among the laureates...

  • SIB’s Swiss-Prot Group co-director Alan Bridge on the future of biocuration

    As announced in May, Alan Bridge is taking up the co-director role of SIB’s Swiss-Prot Group, thus succeeding to Lydie Bougueleret. He gives us his vision of the future for a unique profession, biocuration, and for the Swiss-Prot Group, one of its...

  • SourceData is making data discoverable

    A push for a paradigm change in scientific publication. Bringing to the surface information buried in the figures of scientific papers: this is the purpose of SourceData, an open-access platform developed by EMBO in collaboration with the SIB Swiss...

  • The Drug Design Workshop: tomorrow’s drugs at your fingertips

    Bringing medicinal chemistry and bioinformatics to the layman, by using a didactic online platform based on professional tools, is the goal of the Drug Design Workshop. Developed in 2015 by SIB researchers, together with training and outreach...

  • The genome of a 234-year-old oak tree, young as ever

    A study carried out by researchers at the University of Lausanne (UNIL) and the SIB Swiss Institute of Bioinformatics has revealed that the genome of an emblematic tree of the University campus, the Napoleon oak, has changed little during its first...

  • The quick-change artist strategy of a fungus that causes pneumonia

    A study led by a team of researchers from the Institute of Microbiology of CHUV-UNIL and SIB Swiss Institute of Bioinformatics reveals the mechanisms of antigenic variation used by the pathogen Pneumocystis jirovecii to escape the human immune...

  • Video – RHAPSODY, a project to fight diabetes

    Last September, we were announcing SIB’s participation in a European public-private partnership on Risk Assessment and Progression of Diabetes (RHAPSODY).Watch this short video to learn more about SIB’s role in the project.

  • Vital-IT

    What we do With a multidisciplinary team of scientists and technical staff, Vital-IT maintains a competency centre in bioinformatics and computational biology. Its infrastructure currently spreads across six institutions that maintain...

  • Vital-IT group

    What we do With a multidisciplinary team of scientists and technical staff, at Vital-IT we maintain a competenc ecentre in bioinformatics and computational biology. Our infrastructure currently spreads across six institutions that maintain...